Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction

Publisher： John Wiley & Sons Inc

E-ISSN： 1879-0844|17|10|1006-1014

ISSN： 1388-9842

Source： EUROPEAN JOURNAL OF HEART FAILURE, Vol.17, Iss.10, 2015-10, pp. : 1006-1014

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 4, 2015-04 ,pp. : 393-404

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 10, 2015-10 ,pp. : 1015-1021

John Wiley & Sons Inc

Access to resources Recommend Favorite

Right ventricular dysfunction in left‐sided heart failure with preserved versus reduced ejection fraction

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 19, Iss. 12, 2017-12 ,pp. : 1664-1671

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biomarkers and prognostication in heart failure with reduced and preserved ejection fraction: similar but different?

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 19, Iss. 12, 2017-12 ,pp. : 1648-1650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review

By  

Cardiology, Vol. 136, Iss. 3, 2016-10 ,pp. : 192-203

Karger

Access to resources Recommend Favorite